Article info

Download PDFPDF

Original research
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

Authors

  1. Correspondence to Dr Laura Boekel; l.boekel{at}reade.nl
View Full Text

Citation

Boekel L, Hooijberg F, Vogelzang EH, et al
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

Publication history

  • Received October 15, 2021
  • Accepted February 10, 2022
  • First published April 5, 2022.
Online issue publication 
April 05, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.